Skip to main content
OpenTrials
Completed

NCT Number: NCT01353170

Calcium Concentration in Bicarbonate Hemodialysis (HD)

The study was designed in order to investigate the effects of 3 different dialysate calcium concentrations may exert on mineral metabolism and hemodynamic stability in standard hemodialysis (hd).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nephrology and dialysis unit Miulli General Hospital

Acquaviva delle Fonti, Bari, 70100, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • bicarbonate hd since 6 months
  • uncomplicated hd sessions

Exclusion criteria

  • Incident patients
  • unstable hd patients
  • patients aged less than 18 years

Treatment and study plan

Dialysate calcium concentration

Other

Calcium dialysate concentrations: 1.25, 1.35 and 1.5 mmol/l

Primary outcomes

  1. Serum calcium concentrations

    Time frame: 4 hours

    Evaluation of calcium mass balances and ionized calcium serum concentrations profiling during three hd sessions with different calcium concentrations in the dialysate

Sponsors and collaborators

Lead sponsor

Miulli General Hospital

Other

Registry information

Official study title

Comparison Among Different Dialysate Calcium Concentrations in Bicarbonate Hemodialysis

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
May 12, 2011
Registry last updated
May 12, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.